Effects of aprotinin on anticoagulant monitoring: implications in cardiovascular surgery.
暂无分享,去创建一个
J. Fareed | R. Pifarré | J. Walenga | D. Najman | D. Najman
[1] R. Mohr,et al. Platelet protection by low-dose aprotinin in cardiopulmonary bypass: electron microscopic study. , 1993, The Annals of thoracic surgery.
[2] F. Loop,et al. Aprotinin therapy for reoperative myocardial revascularization: a placebo-controlled study. , 1992, The Annals of thoracic surgery.
[3] R. Mohr,et al. Original articlePlatelet protection by aprotinin in cardiopulmonary bypass: Electron microscopic study , 1992 .
[4] J. E. Doran,et al. Effects of high-dose aprotinin on blood loss, platelet function, fibrinolysis, complement, and renal function after cardiopulmonary bypass. , 1991, The Journal of thoracic and cardiovascular surgery.
[5] H. Teufelsbauer,et al. Effect of intraoperative aprotinin administration on postoperative bleeding in patients undergoing cardiopulmonary bypass operation. , 1991, The Journal of thoracic and cardiovascular surgery.
[6] W. van Oeveren,et al. Increased anticoagulation during cardiopulmonary bypass by aprotinin. , 1990, The Journal of thoracic and cardiovascular surgery.
[7] R. Hart,et al. Hematologic disorders and ischemic stroke. A selective review. , 1990, Stroke.
[8] W. van Oeveren,et al. Aprotinin protects platelets against the initial effect of cardiopulmonary bypass. , 1990, The Journal of thoracic and cardiovascular surgery.
[9] J. Griffin,et al. Aprotinin (trasylol) is a competitive inhibitor of activated protein C. , 1989, Thrombosis research.
[10] V. Boddi,et al. High-dose aprotinin: hemostatic effects in open heart operations. , 1989, The Annals of thoracic surgery.
[11] G. Fraedrich,et al. Reduction of Blood Transfusion Requirement in Open Heart Surgery by Administration of High Doses of Aprotinin - Preliminary Results , 1989, The Thoracic and cardiovascular surgeon.
[12] F. Sebening,et al. Reduction of Homologous Blood Requirement in Cardiac Surgery by Intraoperative Aprotinin Application - Clinical Experience in 152 Cardiac Surgical Patients , 1989, The Thoracic and cardiovascular surgeon.
[13] D. Cosgrove,et al. Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol). , 1989, The Journal of thoracic and cardiovascular surgery.
[14] T. Nilsson,et al. The extrinsic fibrinolytic system in survivors of myocardial infarction. , 1987, Thrombosis research.
[15] A. Montoya,et al. Management of postoperative heparin rebound following cardiopulmonary bypass. , 1981, The Journal of thoracic and cardiovascular surgery.